The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
High Residual Platelet Reactivity After Clopidogrel Loading and Long-term Cardiovascular Events Among Patients With Acute Coronary Syndromes Undergoing PCI
Open accessAbstract
CONTEXT: High residual platelet reactivity (HRPR) in patients receiving clopidogrel has been associated with high risk of ischemic events after percutaneous coronary intervention (PCI). OBJECTIVE: To test the hypothesis that HRPR after clopidogrel loading is an independent prognostic marker of risk of long-term thrombotic events in patients with acute coronary syndromes (ACS) undergoing an invasive procedure and antithrombotic treatment adjusted according to the results of platelet function tests. DESIGN, SETTING, AND PATIENTS: Prospective, observational, referral center cohort study of 1789 consecutive patients with ACS undergoing PCI from April 2005 to April 2009 at the Division of Cardiology of Careggi Hospital, Florence, Italy, in whom platelet reactivity was prospectively assessed by light transmittance aggregometry. INTERVENTIONS: All patients received 325 mg of aspirin and a loading dose of 600 mg of clopidogrel followed by a maintenance dosage of 325 mg/d of aspirin and 75 mg/d of clopidogrel for at least 6 months. Patients with HRPR as assessed by adenosine diphosphate test (≥70% platelet aggregation) received an increased dose of clopidogrel (150-300 mg/d) or switched to ticlopidine (500-1000 mg/d) under adenosine diphosphate test guidance. MAIN OUTCOME MEASURES: The primary end point was a composite of cardiac death, myocardial infarction, any urgent coronary revascularization, and stroke at 2-year follow-up. Secondary end points were stent thrombosis and each component of the primary end point. RESULTS: The primary end point event rate was 14.6% (36/247) in patients with HRPR and 8.7% (132/1525) in patients with low residual platelet reactivity (absolute risk increase, 5.9%; 95% CI, 1.6%-11.1%; P = .003). Stent thrombosis was higher in the HRPR group compared with the low residual platelet reactivity group (6.1% [15/247] vs 2.9% [44/1525]; absolute risk increase, 3.2%; 95% CI, 0.4%-6.7%; P = .01). By multivariable analysis, HRPR was independently associated with the primary end point (hazard ratio, 1.49; 95% CI, 1.08-2.05; P = .02) and with cardiac mortality (hazard ratio, 1.81; 95% CI, 1.18-2.76; P = .006). CONCLUSION: Among patients receiving platelet reactivity-guided antithrombotic medication after PCI, HRPR status was significantly associated with increased risk of ischemic events at short- and long-term follow-up. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01231035.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
Cutlip, D. E., Windecker, S., Mehran, R., Boam, A., Cohen, D. J., van Es, G.-A., Gabriel Steg, P., Morel, M.-A., Mauri, L., Vranckx, P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.685313 · Cited by 5,497
Gurbel, P. A., Bliden, K. P., Hiatt, B. L., & O’Connor, C. M. (2003) · Circulation · doi:10.1161/01.cir.0000072771.11429.83 · Cited by 1,544
Matetzky, S., Shenkman, B., Guetta, V., Shechter, M., Beinart, R., Goldenberg, I., Novikov, I., Pres, H., Savion, N., Varon, D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130846.46168.03 · Cited by 1,354
Price, M. J. (2011) · JAMA · doi:10.1001/jama.2011.290 · Cited by 1,308
Bonello, L., Tantry, U. S., Marcucci, R., Blindt, R., Angiolillo, D. J., Becker, R., Bhatt, D. L., Cattaneo, M., Collet, J. P., Cuisset, T., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.047 · Cited by 1,149
Self-citationBreet, N. J., van Werkum, J. W., Bouman, H. J., Kelder, J. C., Ruven, H. J. T., Bal, E. T., Deneer, V. H., Harmsze, A. M., van der Heyden, J. A. S., Rensing, B. J. W. M., et al. (2010) · JAMA · doi:10.1001/jama.2010.181 · Cited by 850
Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent Thrombosis
Buonamici, P., Marcucci, R., Migliorini, A., Gensini, G. F., Santini, A., Paniccia, R., Moschi, G., Gori, A. M., Abbate, R., & Antoniucci, D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.094 · Cited by 656
Self-citationPrice, M. J., Endemann, S., Gollapudi, R. R., Valencia, R., Stinis, C. T., Levisay, J. P., Ernst, A., Sawhney, N. S., Schatz, R. A., & Teirstein, P. S. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn046 · Cited by 651
Platelet Reactivity in Patients and Recurrent Events Post-Stenting
Gurbel, P. A., Bliden, K. P., Guyer, K., Cho, P. W., Zaman, K. A., Kreutz, R. P., Bassi, A. K., & Tantry, U. S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.041 · Cited by 644
Bonello, L., Camoin-Jau, L., Arques, S., Boyer, C., Panagides, D., Wittenberg, O., Simeoni, M.-C., Barragan, P., Dignat-George, F., & Paganelli, F. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.12.044 · Cited by 556
Marcucci, R., Gori, A. M., Paniccia, R., Giusti, B., Valente, S., Giglioli, C., Buonamici, P., Antoniucci, D., Abbate, R., & Gensini, G. F. (2009) · Circulation · doi:10.1161/circulationaha.108.812636 · Cited by 529
Self-citationPlatelet Function Monitoring in Patients With Coronary Artery Disease
Gurbel, P. A., Becker, R. C., Mann, K. G., Steinhubl, S. R., & Michelson, A. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.051 · Cited by 478
Gurbel, P. A., Bliden, K. P., Butler, K., Antonino, M. J., Wei, C., Teng, R., Rasmussen, L., Storey, R. F., Nielsen, T., Eikelboom, J. W., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.919456 · Cited by 447
Barragan, P., Bouvier, J., Roquebert, P., Macaluso, G., Commeau, P., Comet, B., Lafont, A., Camoin, L., Walter, U., & Eigenthaler, M. (2003) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.10497 · Cited by 434
Angiolillo, D. J., Bernardo, E., Sabaté, M., Jimenez-Quevedo, P., Costa, M. A., Palazuelos, J., Hernández-Antolin, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.05.049 · Cited by 374
BONELLO, L., PAGANELLI, F., ARPIN‐BORNET, M., AUQUIER, P., SAMPOL, J., DIGNAT‐GEORGE, F., BARRAGAN, P., & CAMOIN‐JAU, L. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02609.x · Cited by 281
Bonello, L., Camoin-Jau, L., Armero, S., Com, O., Arques, S., Burignat-Bonello, C., Giacomoni, M.-P., Bonello, R., Collet, F., Rossi, P., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.08.048 · Cited by 276
Valgimigli, M., Campo, G., de Cesare, N., Meliga, E., Vranckx, P., Furgieri, A., Angiolillo, D. J., Sabatè, M., Hamon, M., Repetto, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.833236 · Cited by 226
Frere, C., Cuisset, T., Quilici, J., Camoin, L., Carvajal, J., Morange, P. E., Lambert, M., Juhan-Vague, I., Bonnet, J.-L., & Alessi, M.-C. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-04-0296 · Cited by 204
Cuisset, T., Frère, C., Quilici, J., Morange, P., Mouret, J.-P., Bali, L., Moro, P.-J., Lambert, M., Alessi, M., & Bonnet, J. (2008) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2008.08.018 · Cited by 152
Chin, C. T., Roe, M. T., Fox, K. A. A., Prabhakaran, D., Marshall, D. A., Petitjean, H., Lokhnygina, Y. V., Brown, E., Armstrong, P. W., White, H. D., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.04.022 · Cited by 123
Migliorini, A., Valenti, R., Marcucci, R., Parodi, G., Giuliani, G., Buonamici, P., Cerisano, G., Carrabba, N., Gensini, G. F., Abbate, R., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.883454 · Cited by 118
Self-citationCuisset, T., Frère, C., Quilici, J., Gaborit, B., Castelli, C., Poyet, R., Bali, L., Morange, P., Alessi, M., & Bonnet, J. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.06.007 · Cited by 73
Platelet function in clopidogrel-treated patients with acute coronary syndrome
Sibbing, D., von Beckerath, O., Schömig, A., Kastrati, A., & von Beckerath, N. (2007) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3280d21aed · Cited by 42
Cited by
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
2014 ESC/EACTS Guidelines on myocardial revascularization
Kolh, P., Windecker, S., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu366 · Cited by 4,199
Tantry, U. S., Bonello, L., Aradi, D., Price, M. J., Jeong, Y.-H., Angiolillo, D. J., Stone, G. W., Curzen, N., Geisler, T., ten Berg, J., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.101 · Cited by 910
Self-citationStone, G. W., Witzenbichler, B., Weisz, G., Rinaldi, M. J., Neumann, F.-J., Metzger, D. C., Henry, T. D., Cox, D. A., Duffy, P. L., Mazzaferri, E., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61170-8 · Cited by 857
Metadata
- Authors
- Parodi, G., Marcucci, R., Valenti, R., Gori, A. M., Migliorini, A., Giusti, B., Buonamici, P., Gensini, G. F., Abbate, R., & Antoniucci, D.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2011-09-21
- Volume
- 306
- Issue
- 11
- Pages
- 1215
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2029179690
- Cited by
- 404
- References
- 24
- FWCI
- 32.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.